Paving the way for High-throughput Organoid ENgineering using Integrated acoustiX

PHOENIX aims to develop a microfluidic technology for high-throughput generation of vascularized cerebral organoids, enhancing reproducibility and maturation through acoustophoresis and two-photon writing.

Subsidie
€ 2.832.500
2023

Projectdetails

Introduction

The aim of PHOENIX is to use my expertise in microsystems engineering to close critical technology gaps in organoid generation. Cerebral organoids are 3D self-assembled structures derived from human induced pluripotent stem cells, replicating both structure and function of the human foetal brain. Organoids have the potential to replace existing 2D cell cultures and animal models, but this has not yet been realized due to rudimentary preparation methods.

Technology Gaps

In PHOENIX, three important technology gaps will be addressed:

  1. Reproducibility
  2. Controlled maturation
  3. Vascularisation

I aim to build on my pioneering research on droplet acoustofluidics and the scientific output of my ERC Starting Grant to develop three microfluidic modules that, at the end of the project, shall be integrated into a seamless organoid engineering pipeline.

Methodology

The technology in focus is acoustophoresis, a method to manipulate particles and cells by ultrasound. This will be used to achieve ordered encapsulation of stem cells in hydrogel droplets and develop a microfluidic platform where the cells can be differentiated under fully controlled conditions.

Finally, two-photon writing will be used to integrate a vascular network with the organoid constructs to form an important delivery architecture for nutrients and blood components. PHOENIX will be focused on both technology development and thorough biological characterization of the resulting organoids to demonstrate both expected and unexpected benefits of transferring organoid generation on-chip.

Collaborations

Collaborations have been established with:

  • Prof. Christine Mummery and Dr. Valeria Orlova, both at LUMC, NL
  • Dr. Anna Falk at KI, SE

These collaborations will provide expertise in complementary fields of this highly interdisciplinary project.

Expected Output

The expected output of PHOENIX is a microfluidic technology that enables high-throughput generation of cerebral organoids with a multi-regional structure and vascularisation in a direct process.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.832.500
Totale projectbegroting€ 2.832.500

Tijdlijn

Startdatum1-4-2023
Einddatum31-3-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • UPPSALA UNIVERSITETpenvoerder

Land(en)

Sweden

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Reprogramming of somatic cells into organOids: patient-centred neurodevelopmental disease modelling from nascent induced pluripotency

The project aims to develop a robust method for generating human brain organoids from patients with Fragile X Syndrome to explore neurodevelopmental phenotypes and inform targeted therapies.

€ 2.500.000
ERC Proof of...

High Throughput Modelling and Measurement of Human Epithelial Models using Electrospun Conducting Polymers For Unlocking Data-Driven Drug Discovery

The project aims to enhance drug discovery by developing simplified Organ on Chip platforms through hydrogel electrospinning, enabling scalable monitoring and integration into industry workflows.

€ 150.000
ERC Proof of...

Directed Orchestration of Microfluidic Environments for guided Self-organisation

The project develops the DOMES microfluidic platform to study environmental impacts on kidney organogenesis, enhancing understanding of congenital anomalies through advanced 3D cell culture models.

€ 150.000
ERC Starting...

Inducing functionality in retinal organoids with electrical activities derived from developing retina

This project aims to enhance the functionality of retinal organoids by using electrophysiological insights from mouse retina development and mathematical models to induce naturalistic electrical features.

€ 1.498.364
ERC Proof of...

An automated platform for the large-scale production of miniaturized neuromuscular organoids

The project aims to automate and scale the production of complex neuromuscular organoids for high-throughput drug screening to advance therapies for neuromuscular diseases.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Origami Paper-based tecHnology fOr the innovativE aNd sustaInable Organ-on-Chip devices

The PHOENIX-OoC project aims to revolutionize Organ-on-Chip technology by developing origami paper-based devices for cell co-cultures and pharmacological studies, enhancing sustainability and functionality.

€ 2.202.333
EIC Pathfinder

Revolutionary high-resolution human 3D brain organoid platform integrating AI-based analytics

The 3D-BrAIn project aims to develop a personalized bio-digital twin of the human brain using advanced organoid cultures and machine learning to enhance precision medicine for CNS disorders.

€ 1.998.347
EIC Transition

IDEFIX Multiorgan toxicity and efficacy test platform

Cherry Biotech's IDEFIX project aims to revolutionize preclinical drug testing by developing a customizable organ-on-chip platform that mimics human multiorgan physiology, enhancing efficacy and toxicity predictions.

€ 2.496.073
EIC Pathfinder

Next Generation 3D Tissue Models: Bio-Hybrid Hierarchical Organoid-Synthetic Tissues (Bio-HhOST) Comprised of Live and Artificial Cells.

Bio-HhOST aims to create bio-hybrid materials with living and artificial cells for dynamic communication, enhancing tissue modeling and reducing animal use in drug research.

€ 1.225.468
EIC Pathfinder

High-throughput ultrasound-based volumetric 3D printing for tissue engineering

SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.

€ 2.999.625